Vrij Nederland continues independently

WPG Publishers has bid farewell to the magazine Vrij Nederland, which will continue independently. Sander Heijne has been appointed the new editor-in-chief as of April 1, 2024. Vrij Nederland will collaborate with Pakhuis de Zwijger. We advised WPG Publishers.

Methaplanet raises EUR 6M

Methaplanet, an innovative scale-up focused on preparing and optimizing agricultural waste streams to enhance their utilization in biogas plants, has completed a €6M investment round led by ABP, with backing from EIT InnoEnergy and business angels. Methaplanet makes energy pellets from manure that contains a lot of straw, which can be used to produce biogas more efficiently. Olym advised lead investor ABP on this investment round.

Intrinsic ID acquired by Synopsys

Synopsys, Inc. (Nasdaq: SNPS) has acquired Intrinsic ID, a leading provider of Physical Unclonable Function (PUF) IP used in the design of system-on-chips (SoCs). Intrinsic ID is a spin-out of Royal Philips Electronics. We advised the company and its selling shareholders including Prime Ventures and Robert Bosch Venture Capital.

MoonPay Joins Forces with Onramper

We advised Onramper on their strategic transaction with industry leader MoonPay which will democratize access to cryptocurrencies worldwide. Onramper is a leading fiat-to-crypto payments aggregator. The collaboration is set to offer MoonPay’s clients a comprehensive solution to optimize conversion rates across various regions.

Boss Transport acquires Datrans Transport

Boss Transport has acquired Datrans Nederland BV and Datrans GmbH with the aim of increasing transport to Switzerland. Boss Transport transports through countries such as Switzerland, Germany, Austria, France, Denmark, Italy and the Benelux. We advised Boss Transport on this acquisition.

TIBO Energy raises EUR 3M in seed round

Eindhoven-based TIBO Energy, a company that manages network congestion, saves energy costs and reduces emissions with smart grid management, has secured €3M in a seed round of funding, to expand its team and venture into international markets. The investment was led by Amsterdam-based SET Ventures, with contributions from Speedinvest and TIBO Energy’s founding team members. Wij adviseerden SET Ventures bij deze investering.

Helin raises EUR 3M in seed round

Helin, an industrial edge intelligence platform, has closed a €3 million seed funding round led by FORWARD.one. The fresh capital infusion will primarily be allocated towards expanding Helin’s commercial and development teams, and further enhancing its state-of-the-art industrial edge intelligence SaaS platform. We advised FORWARD.one on this investment.

Farmless raises EUR 4.8M in seed round

Amsterdam-based Farmless, a startup that aims to turn renewable energy and CO2 into carbon-negative food ingredients, has secured €4.8M in a seed round of funding. The investment was co-led by World Fund and Vorwerk Ventures. Farmless, which is crafting eco-friendly, functional proteins with a full amino acid profile, plans to use the proceeds for constructing a pilot protein brewery in Amsterdam. The funds will also support the development of Farmless’ fermentation platform and facilitate ongoing regulatory approval processes. We advised World Fund and Vorwerk Ventures on this investment.

Marketer acquires Moving Digital

Marketer has acquired the Dutch proptech company Moving Digital. Moving Digital specializes in digital marketing solutions for the existing homes market, offering services such as lead generation, campaign automation, performance and analytics, and sustainability reports. We advised the selling shareholders of Moving Digital on this transaction.

InnovationQuarter invests in Synerkine Pharma

Synerkine Pharma, a Dutch biopharmaceutical company creating innovative pain solutions, has closed an extension of its Series A financing led by Flerie with support from new investors, InnovationQuarter and Utrecht Health Seed Fund, and existing investor Thuja Capital. The equity financing is accompanied by a matching innovation credit from Rijksdienst voor Ondernemend (RVO) Nederland – the Netherlands Enterprise Agency. The total new proceeds of EUR 12.1 million will be used to accelerate the development of Synerkine Pharma’s lead asset SK-01, a therapeutically active cytokine fusion protein, into clinical studies in complex regional pain syndrome (CRPS), a severe chronic pain indication. We advised InnovationQuarter on this investment.